New vaccine patch has showed no negative side effects and could lead to a replacement of needle-based vaccination methods.
List view / Grid view
Filter the results
Kenya has become the third African country to introduce the world’s first malaria vaccine into the country, in a phased pilot programme.
The FDA has awarded a breakthrough therapy designation to an investigational prophylactic vaccine to treat respiratory syncytial virus in seniors.
A recent report has predicted that the cervical cancer vaccine market will increase to $6bn by the end of the forecast period.
An investigational Zika vaccine currently being evaluated in a Phase I study has been given a Fast Track designation by the FDA.
A new process developed by the University of Bath protects a TB antigen and a novel vaccine adjuvant from heat damage.
Researchers have detailed recent breakthrough experiments that successfully immunised mice against the Candida auris infection.
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
The health minister for the Democratic Republic of the Congo has stated an experimental Ebola vaccine will not be trialled in the country.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
A medical centre in Hong Kong had 76 boxes of an HPV vaccine seized after a complaint from a patient who experienced adverse side effects.